These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29522642)

  • 21. New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study.
    Maccallini C; Gallorini M; Sisto F; Akdemir A; Ammazzalorso A; De Filippis B; Fantacuzzi M; Giampietro L; Carradori S; Cataldi A; Amoroso R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1632-1645. PubMed ID: 34289751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
    Yadav MR; Barmade MA; Tamboli RS; Murumkar PR
    Eur J Med Chem; 2015 Nov; 105():1-38. PubMed ID: 26469743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
    Stauffer F; Furet P; Floersheimer A; Lang M
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
    Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
    Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues.
    Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM
    Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel oxadiazole-thiadiazole derivatives: synthesis, biological evaluation, and
    Evren AE; Nuha D; Dawbaa S; Karaduman AB; Sağlik BN; Yurttaş L
    J Biomol Struct Dyn; 2024 Oct; 42(16):8688-8700. PubMed ID: 37587853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel aromatase inhibitors by structure-guided design.
    Ghosh D; Lo J; Morton D; Valette D; Xi J; Griswold J; Hubbell S; Egbuta C; Jiang W; An J; Davies HM
    J Med Chem; 2012 Oct; 55(19):8464-76. PubMed ID: 22951074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
    Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
    Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
    Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
    Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
    Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel sulfonanilide analogs decrease aromatase activity in breast cancer cells: synthesis, biological evaluation, and ligand-based pharmacophore identification.
    Su B; Tian R; Darby MV; Brueggemeier RW
    J Med Chem; 2008 Mar; 51(5):1126-35. PubMed ID: 18271519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and molecular docking of N,N'-disubstituted thiourea derivatives as novel aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Anuwongcharoen N; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Chem; 2018 Sep; 79():171-178. PubMed ID: 29758407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives.
    Ertas M; Sahin Z; Bulbul EF; Bender C; Biltekin SN; Berk B; Yurttas L; Nalbur AM; Celik H; Demirayak Ş
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900033. PubMed ID: 31475759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
    Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
    ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
    Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
    BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some Thiazole Derivatives Combined with Different Heterocycles: Cytotoxicity Evaluation and Apoptosis Inducing Studies.
    Yurttaş L; Demir B; Çiftçi GA
    Anticancer Agents Med Chem; 2018; 18(8):1115-1121. PubMed ID: 29595114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents.
    Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES
    Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
    Bonfield K; Amato E; Bankemper T; Agard H; Steller J; Keeler JM; Roy D; McCallum A; Paula S; Ma L
    Bioorg Med Chem; 2012 Apr; 20(8):2603-13. PubMed ID: 22444875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells.
    Su B; Chen S
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6733-5. PubMed ID: 19854050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.